Brief Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. May 16, 2013; 5(5): 251-254
Published online May 16, 2013. doi: 10.4253/wjge.v5.i5.251
Endoscopic ultrasonography in patients with elevated carbohydrate antigen 19-9 of obscure origin
Jae Hoon Cheong, Gwang Ha Kim, Ji Yoon Moon, Bong Eun Lee, Dong Yup Ryu, Dong Uk Kim, Hyung-Il Seo, Geun Am Song
Jae Hoon Cheong, Gwang Ha Kim, Ji Yoon Moon, Bong Eun Lee, Dong Yup Ryu, Dong Uk Kim, Geun Am Song, Department of Internal Medicine, Pusan National University School of Medicine, and Biomedical Research Institute, Pusan National University Hospital, Busan 602-739, South Korea
Hyung-Il Seo, Department of Surgery, Pusan National University School of Medicine, Busan 602-739, South Korea
Author contributions: Kim GH and Song GA designed the research; Moon JY, Lee BE, Ryu DY and Seo HI analyzed the data; Cheong JH and Kim GH wrote the paper; Kim GH and Kim DU performed the research.
Supported by A grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea, No. 0920050; Pusan National University Hospital Clinical Research Grant (2012)
Correspondence to: Dr. Gwang Ha Kim, MD, Department of Internal Medicine, Pusan National University School of Medicine, and Biomedical Research Institute, Pusan National University Hospital, 1-10, Ami-dong, Seo-gu, Busan 602-739, South Korea. doc0224@pusan.ac.kr
Telephone: +82-51-2407869 Fax: +82-51-2448180
Received: May 12, 2012
Revised: September 13, 2012
Accepted: February 5, 2013
Published online: May 16, 2013
Abstract

AIM: To evaluate the efficacy of endoscopic ultrasonography (EUS) in patients with elevated carbohydrate antigen (CA) 19-9 levels of obscure origin.

METHODS: Patients who had visited Pusan National University Hospital because of elevated serum CA 19-9 levels, between January 2007 and December 2009, were retrospectively enrolled. EUS had been performed on all subjects, in addition to routine blood tests, endoscopy, abdominal computed tomography (CT) and other clinical exams, which had not revealed any abnormal findings suggestive of the origin of the elevated CA 19-9 levels.

RESULTS: Of the 17 patients, gallbladder sludge was detected in 16 patients (94.1%) and common bile duct sludge was observed in 3 patients (17.6%). After the administration of ursodeoxycholic acid to 12 of the patients with gallbladder sludge, CA 19-9 levels normalized in 6 of the patients after a median of 4.5 mo.

CONCLUSION: EUS is a useful diagnostic method for patients with elevated CA 19-9 levels of obscure origin, even if the reason for abnormal levels of this serum marker cannot be determined through prior examinations, including abdominal CT.

Keywords: Carbohydrate antigen 19-9, Endoscopic ultrasonography, Gallbladder, Ursodeoxycholic acid